Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,689 across all filing types
Latest filing 2021-06-23 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
关于获得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company about receiving invention patent certificates. It details patent numbers, inventors, application dates, and the significance of the patents to the company's operations. There is no financial data, no mention of financial results, no regulatory filings related to financial performance, no management changes, no voting results, no capital changes, or any other financial or governance report. The document is an announcement of intellectual property achievements, which does not fit into any of the specific financial or regulatory filing categories. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous announcements that do not fit other categories. The document length is short (1144 characters), and it is a standalone announcement, not a report or a presentation.
2021-06-23 Chinese
关于获得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the receipt of an invention patent certificate by the company. It contains no financial data, no mention of financial results, no regulatory filings related to financial performance, and no meeting or voting information. It is a corporate announcement about intellectual property rights, not a financial or regulatory report. The document length is only 610 characters, indicating it is a brief announcement. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings related to financial matters. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2021-06-20 Chinese
关于公司获得医疗器械注册证及申报医疗器械注册获得受理的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of medical device registration certificates and acceptance notices for medical device registration applications. It includes details about product registration changes and the acceptance of new product registrations by regulatory authorities. The document is an official announcement of regulatory approvals and application statuses, not a financial report, management change, or shareholder meeting material. It does not contain financial data or detailed financial analysis. The document is short (1268 characters) and serves as a regulatory update. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-06-08 Chinese
关于公司产品获得CE认证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of CE certification for three medical device products. It includes product descriptions, the significance of the certification, and a statement about the impact on future business. There is no financial data, no mention of a report being attached or published, no regulatory filings or certifications, and no discussion of financial results or management changes. The document is a regulatory announcement about product certification, which does not fit into financial reports or management disclosures. Given the nature and length (1090 characters), it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2021-06-08 Chinese
2020年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is titled as an announcement regarding the implementation of the 2020 annual equity distribution (dividend) by Dirui Medical Technology Co., Ltd. It details the dividend amount per share, the total dividend payout, the record date, the ex-dividend date, and the method of dividend distribution. It references the approval of the dividend plan at the 2020 annual general meeting and provides specifics on the dividend payment schedule and tax treatment. The document is an announcement of the dividend distribution implementation rather than the dividend policy proposal or the full annual report. It does not contain comprehensive financial statements or management discussion but focuses on the dividend payment details. Therefore, it fits the category of Notice of Dividend Amount (DIV). The document length is 2724 characters, which is consistent with a detailed dividend announcement rather than a full report.
2021-06-04 Chinese
迪瑞医疗：关于2020年度权益分派事项的独立董事意见
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an independent director's opinion on the 2020 annual equity distribution plan of the company. It discusses dividend distribution details, share repurchase, and adjustments to the distribution plan. The document is short (978 characters) and focuses on voting and approval of dividend distribution, not the full dividend report or financial statements. It is not a full Annual Report, Earnings Release, or Interim Report. It is not a proxy solicitation or AGM presentation. The content aligns with a Declaration of Voting Results & Voting Rights Announcement related to dividend distribution approval and confirmation by independent directors. Therefore, the best fitting category is Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-06-04 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.